TP53 and ovarian cancer: In mechanism-based studies, silencing PADI4 by siRNA inhibited the proliferation of p53 wild-type A2780 cells and p53-null SKOV3 cells, suggesting that PAD4 is involved in the regulation of ovarian cancer cell proliferation mediated through a p53-independent signaling pathway [236].